Radiation before liver surgery may help shrink tumors and grow healthy tissue
NCT ID NCT05195710
First seen Nov 10, 2025 · Last updated Jun 06, 2026 · Updated 32 times
Summary
This study is for people with colorectal cancer that has spread to the liver and cannot be removed right away because the healthy part of the liver is too small. Doctors will use a treatment called Y-90 radioembolization to deliver radiation directly to the tumor side of the liver. The goal is to shrink the tumors and help the healthy side grow larger so surgery to remove the cancer becomes possible. About 50 participants will take part to see if this approach is safe and feasible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.